FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
VentriPoint Diagnostics Ltd. Stock AnalysisComprehensive stock analysis for VentriPoint Diagnostics Ltd. (VPTDF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisVPTDF
VPTDF
VentriPoint Diagnostics Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
VPTDF
Home🔹Stocks🔹VentriPoint Diagnostics Ltd.

VentriPoint Diagnostics Ltd.

VPTDF•OTC

VentriPoint Diagnostics Ltd.

VPTDF•OTC
Market cap
$13.07M
Sentiment

Your view on VPTDF

Mkt Cap
$13.07M
Sentiment
Your view
VPTDF
VentriPoint Diagnostics Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
VPTDF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About VentriPoint Diagnostics Ltd.

Industry
Medical - Devices
Sector
Healthcare
CEO
Hugh MacNaught
Headquarters
18 Hook Avenue, Toronto, ON, CA
Industry
Medical - Devices
Sector
Healthcare
CEO
Hugh MacNaught
Headquarters
18 Hook Avenue, Toronto, ON, CA
Description

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News